Ela Pharma Ltd.

Ela Pharma Ltd. is a pioneering biotechnology company dedicated to the development of innovative therapeutics aimed at enhancing patient recovery and care. Focusing on critical clinical applications such as organ preservation, retinal artery occlusion, acute ischemic conditions, and acute liver failure, Ela Pharma leverages its proprietary technology of small molecules to inhibit intracellular proteolytic enzymes, targeting novel anti-necrotic based pathways.

Located at Aryeh Dulchin 16/6, Tel-Aviv, Israel 69360, Ela Pharma is committed to advancing life science through groundbreaking research and development. The company's expertise lies in inhibiting enzymes and regulating necrosis to develop effective treatments for conditions such as brain injury, ischemic heart disease, and other tissue-degrading ailments. Ela Pharma's commitment to biotechnology development positions it as a key player in the future of medical therapeutics.

With a focus on cell necrosis and organ preservation, Ela Pharma is poised to make significant contributions to the field of biotechnology. Ela Pharma Ltd. invites you to explore opportunities for collaboration and partnership as it continues to push the boundaries of medical science. We invite the manager of Ela Pharma Ltd. to create a customized and exclusive company showcase and product listing on our platform to further highlight their innovative work.